Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
clinical trials
eli lilly
fda
life sciences
migraine
3
×
national blog main
allergan
biohaven
calcitonin gene-related peptide
drugs
indiana blog main
indiana top stories
national
national top stories
new york blog main
teva pharmaceutical
abbvie
alder biopharmaceutical
american academy of neurology
atogepant
bob azelby
boston blog main
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
cgpr
chronic migraine
detroit blog main
detroit top stories
episodic migraine
eptinezumab
erenumab
europe blog main
fremanezumab
galcanezumab
impel neuropharma
What
class
3
×
fda
migraine
new
approval
approved
drug
medicines
won
adults
allergan
announced
arguments
big
commercialized
companies
competitors
decades
decision
developed
drugs
eli
headache
late
lilly
make
marks
meeting
monday
neuro
nod
oral
pain
pill
potential
prevent
starts
therapies
thursday
treat
Language
unset
Current search:
class
×
migraine
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines